Affibody AB
ABActiveOrg 5566656913Scheeles Väg 2, 171 65 SolnaResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2004 · 22 years old66 employees
Loading company…
Overview
Affibody AB is a Swedish AB based in Solna, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2004, the company has 66 employees and reported revenue of SEK 25.9m in its latest annual filing.
Revenue 2025
25.9M SEK
+10% vs 2024
EBITDA margin
−572.0 %
+32% vs 2024
Net profit 2025
-148.1M SEK
+32% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
-276.6 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
0.2×
Very weakAmong the 10% lowest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
-407.4 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
EBITDA — year on year
SEK millionsKey figures
Annual report 2025| Revenue | 25.9M SEK | +10% |
| EBITDA | -148.4M SEK | +32% |
| Net profit | -148.1M SEK | +32% |
| Total assets | 36.3M SEK | -24% |
| Equity | -100.5M SEK | -56% |
| Employees | 66 | — |
Company information
Legal name
Affibody AB
Org number
5566656913
Legal form
Aktiebolag
Founded
1 September 2004 · 22 years
Share capital
SEK 100,000
Employees
66 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att, direkt eller indirekt, bedriva forskning och utveckling inom bioteknologi, marknadsföra, sälja och licensiera produkter och forskningsresultat inom bioteknologi samt bedriva annan därmed förenlig verksamhet. Bolaget skall vidare kunna äga och handla med aktier och värdepapper.
(no translation available)
Contact
Address
Scheeles Väg 2, 171 65 Solna
Email
reception@affibody.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Affibody AB reported revenue of SEK 25.9m, an increase of 10% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 148.1m, and the EBITDA margin stood at -572%.
At the end of 2025, current assets covered short-term debt 0.2 times.
Financials
Revenue
SEK millionsEBITDA
SEK millionsIncome statement
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 25,942 | 23,545 | 191,799 | 226,647 | 284,712 |
| Staff expenses | — | — | — | — | — |
| EBITDA | -148,397 | -218,985 | -99,099 | -119,805 | -139,409 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | -148,397 | -218,985 | -99,099 | -119,805 | -139,409 |
| Net financials | 1,042 | 2,059 | 733 | 41 | — |
| Profit before tax | -147,355 | -216,926 | -98,367 | -119,764 | -139,409 |
| Tax | -715 | -0 | -2,926 | -0 | -0 |
| Net profit | -148,070 | -216,926 | -101,293 | -119,764 | -139,409 |
Balance sheet
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 36,344 | 47,717 | 161,271 | 90,051 | 242,891 |
| Equity | -100,517 | -64,447 | 57,479 | 53,772 | 148,536 |
| Long-term debt | 0 | 0 | 0 | 0 | 437 |
| Short-term debt | 136,857 | 106,325 | 99,964 | 33,452 | 93,917 |
| Total debt | 136,857 | 106,325 | 99,964 | 33,452 | 94,354 |
Financial ratios
5-year trendEBITDA margin
-572.0 %
20212025
Equity ratio
-276.6 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
Return on equity
—
20212025
Net profit margin
-570.8 %
Very weakAmong the 10% lowest rated companies in the industry
20212025
Asset turnover
0.71×
AverageAround the average of companies in the same industry
20212025
Debt / equity
—
20212025
Sector performance
18 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Operating marginVery weak
Among the 10% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery weak
Among the 10% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on assets (ROA)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Basic earning power (BEP)Very weak
Among the 10% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Return on equity (ROE)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on net assets (RONA)Not rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery weak
Among the 10% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery weak
Among the 10% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 20% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash conversion ratioAverage
Around the average of companies in the same industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Debt & solvency
Solidity ratioVery weak
Among the 10% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery weak
Among the 10% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Income to debtVery weak
Among the 10% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 20% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 10% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtAverage
Around the average of companies in the same industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 10% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalVery weak
Among the 10% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in debtWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
One-year change in equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's equity.
Annual reports & filings
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DO Chief Executive Officer | Chief Executive Officer | 2021 |
JT Chief Auditor | Chief Auditor | 2025 |
Former (1)
AK Chief Auditor | Chief Auditor | 2021 – 2025 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DO Board of Directors | Board of Directors | 2021 |
AK Deputy Board Member | Deputy Board Member | 2022 |
Former (1)
JG Deputy Board Member | Deputy Board Member | 2021 – 2022 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Related companies
Company hierarchy
Patricia Industries II AB
Affibody AB Board network connections
Board members of Affibody AB also hold positions in 76 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Kristina Svanberg | Chief Auditor | 41 companiesMany roles |
| Jakob Tomas Christoffer Grunditz | Chief Auditor | 25 companiesMany roles |
| David Olof Rikard Bejker | Chief Executive Officer | 6 companiesMany roles |
| Johan Gabriel Waltersson Stuart | Deputy Board Member | 4 companies |
Frequently asked questions
What is the Org number of Affibody AB?
Affibody AB is registered with Bolagsverket / SCB under Org 5566656913.
What is the revenue of Affibody AB?
Affibody AB reported revenue of SEK 25.9m in 2025.
How many employees does Affibody AB have?
Affibody AB employs 66 people as of the latest annual report.
Who is the CEO of Affibody AB?
David Olof Rikard Bejker is the CEO of Affibody AB, in role since 2021.
Where is Affibody AB headquartered?
Affibody AB's registered address is Scheeles Väg 2.